← Eichor
Study identifier: NCT05853692 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Prevention of Oral Mucositis in Head and Neck Cancer.

Condition: Oral Mucositis  ·  Sponsor: Catholic University of the Sacred Heart

PhaseNA
Planned participants130
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Oral Mucositis (OM) consists in the painful inflammation and ulceration of the mucous membranes lining the digestive tract, lasting between 7 and 98 days; and starts as an acute inflammation of oral mucosa, tongue, and pharynx after RT exposure. Gel X spray is a product based on zinc gluconate. It could be helpful to achieve the prevention of Oral Mucositis and, in case of OM manifestation, the reduction of oral pain symptoms and to accelerate the healing process of oral mucositis ulcerations. The aim of this study is to demonstrate the efficacy of the treatment with Gel X to reduce the incidence of oral mucositis, in comparison with Sodium Bicarbonate.

This description comes directly from the study's public registry record.

Talk to the study team

Carlo Lajolo, Prof.  ·  +393401004585  ·  carlo.lajolo@unicatt.it

Always discuss trial participation with your own doctor first.

Locations (1)

Catholic University of the Sacred HearthRoma, Italy, ItalyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05853692